Symbol="GRTX"
AssetType="Common Stock"
Name="Galera Therapeutics Inc"
Description="Galera Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of therapies for the transformation of radiation therapy in cancer. The company is headquartered in Malvern, Pennsylvania."
CIK="1563577"
Exchange="NASDAQ"
Currency="USD"
Country="USA"
Sector="LIFE SCIENCES"
Industry="PHARMACEUTICAL PREPARATIONS"
Address="2 WEST LIBERTY BLVD #100, MALVERN, PA, US"
FiscalYearEnd="December"
LatestQuarter="2023-03-31"
MarketCapitalization="125288000"
EBITDA="-51850000"
PERatio="None"
PEGRatio="None"
BookValue="-2.275"
DividendPerShare="0"
DividendYield="0"
EPS="-2.52"
RevenuePerShareTTM="0"
ProfitMargin="0"
OperatingMarginTTM="0"
ReturnOnAssetsTTM="-0.496"
ReturnOnEquityTTM="-10.63"
RevenueTTM="0"
GrossProfitTTM="0"
DilutedEPSTTM="-2.52"
QuarterlyEarningsGrowthYOY="0"
QuarterlyRevenueGrowthYOY="0"
AnalystTargetPrice="7.75"
TrailingPE="-"
ForwardPE="-"
PriceToSalesRatioTTM="-"
PriceToBookRatio="29.39"
EVToRevenue="-"
EVToEBITDA="-0.0899"
Beta="1.77"
num_52WeekHigh="3.59"
num_52WeekLow="1.12"
num_50DayMovingAverage="3.054"
num_200DayMovingAverage="2.199"
SharesOutstanding="42906800"
DividendDate="None"
ExDividendDate="None"
symbol="GRTX"
open="2.95"
high="3.02"
low="2.90"
price="2.93"
volume="530755.00"
latest_trading_day="2023-07-07"
previous_close="2.92"
change="0.01"
change_percent="0.3425%"
aroon_positive_momentum_days="0"
aroon_negative_momentum_days="5"
trend_strength="Absent or Weak Trend"
buying_signal="High Volatility / Hold Signal"
volume_analysis="Target Volume"
value_analysis="Expected Range"
Aroon_change="FALSE"
Aroon_momentum="95"
Volume_recent_avg="756871"
Change_recent_avg="-0.01"
Delta_recent_avg="0.2"
Variance_recent_avg="0.1"
Change_ratio_recent_avg="-0.37"
RSI_change="FALSE"
ADX_change="FALSE"

event="FALSE"
Aroon_signal="negative"
Aroon_change="FALSE"
Aroon_momentum_positive="95"
Aroon_momentum_negative="5"
image_negative_thumbnail_id_1="1132"
image_negative_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Negative_Landscape_0165.jpeg"
image_negative_thumbnail_id_2="1101"
image_negative_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Negative_Landscape_0134.jpeg"
image_neutral_thumbnail_id_1="589"
image_neutral_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0010.jpeg"
image_neutral_thumbnail_id_2="585"
image_neutral_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0014.jpeg"
image_positive_thumbnail_id_1="961"
image_positive_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0123.jpeg"
image_positive_thumbnail_id_2="683"
image_positive_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0025.jpeg"
image_professor_thumbnail_id_1="1196"
image_professor_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0030.jpeg"
image_professor_thumbnail_id_2="1194"
image_professor_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0028.jpeg"
